echoloc/ Companies/ Viridian Therapeutics, Inc.

Company profile

Viridian Therapeutics, Inc. Tech Stack

Antibody-engineered therapies for thyroid eye disease and autoimmune conditions

Biotechnology Research Waltham, Massachusetts 201–500 employees Founded 2007 Public Company

Viridian Therapeutics develops engineered antibody candidates for thyroid eye disease and FcRn-driven autoimmune diseases. Its stack pairs clinical tooling (SAS, CDISC, Veeva Safety, IQVIA) with commercial-readiness systems like Veeva CRM and PromoMats, plus public-company finance tools (Workiva, FloQast, NetSuite). Director-heavy hiring in biostatistics and medical affairs, alongside injectable device and CMO validation work, points to a company preparing for commercialization.

Tech Stack 26 technologies

Core StackSAS Python NetSuite Tableau Power BI Kubernetes Terraform CloudFormation Agiloft ADP Workforce Now Concur Veeva Safety CDISC UKG IQVIA JMP GraphPad Prism Minitab FlowJo Veeva PromoMats Veeva CRM Workiva FloQast Veeva Vault Adaptive Planning Veeva

What Viridian Therapeutics, Inc. Is BuildingChallenges and projects from their job posts

◆Challenges

Rare disease clinical development complexity
Scaling accounting for GAAP and SEC compliance
Data dissemination and enterprise data governance gaps
Building secure, compliant, scalable systems
Managing vendor relationships and value

▲Active Projects

Monoclonal antibody clinical studies
Injectable delivery device with human factors assessments
Manufacturing process validation at CMOs
Clinical-trial data repository
Clinical trial simulation and advanced statistical modeling
Refining medical affairs strategy

Hiring Activity

Accelerating15 roles · 8 in 30d

Department

Research

Finance

Healthcare

Manufacturing

Data

Engineering

Ops

Product

Seniority

Director

Senior

Manager

Notable leadership hires: Biostatistics Director, Medical Affairs Director

Companies like Viridian Therapeutics, Inc.

100+ Biotechnology Research companies running SAS and Python

See the full list

About Viridian Therapeutics, Inc.

Viridian Therapeutics is a public biopharmaceutical company headquartered in Waltham, Massachusetts, founded in 2007. It uses antibody discovery and protein engineering to build therapeutic candidates against validated drug targets in established disease areas. Its lead program, VRDN-001, is in two global Phase 3 trials for active and chronic thyroid eye disease, with VRDN-003 being developed as a subcutaneous option. The company is also advancing FcRn inhibitors VRDN-006 and VRDN-008 for autoimmune indications. Viridian employs 201–500 people and is currently hiring in the United States.

HeadquartersWaltham, Massachusetts

Company Size201–500 employees

Founded2007

Hiring MarketsUnited States

Frequently Asked Questions

What tech stack does Viridian Therapeutics use?

Viridian uses SAS, Python, CDISC, IQVIA and Veeva Vault and Safety for clinical work, Veeva CRM and PromoMats commercially, and NetSuite, Workiva, FloQast and Adaptive Planning for finance.

Is Viridian Therapeutics hiring?

Yes. Hiring is accelerating in the United States, weighted toward director and senior roles across research, finance, healthcare and manufacturing, including Biostatistics Director and Medical Affairs Director.

What is Viridian Therapeutics working on?

Viridian is running monoclonal antibody clinical studies, building clinical trial simulation models and a clinical-trial data repository, and developing an injectable drug delivery device.

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size

Alamar Biosciences, Inc.

Biotechnology Research

Ardelyx, Inc.

Biotechnology Research

Rhythm Pharmaceuticals Inc.

Biotechnology Research

X-Chem, Inc.

Biotechnology Research

How this profile is built

Viridian Therapeutics, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.